Leone D. Patterson - Apr 3, 2025 Form 3 Insider Report for Kalaris Therapeutics, Inc. (KLRS)

Role
Director
Signature
/s/ Andrew Oxtoby, Attorney-in-Fact
Stock symbol
KLRS
Transactions as of
Apr 3, 2025
Transactions value $
$0
Form type
3
Date filed
4/4/2025, 08:21 AM
Previous filing
Jan 10, 2025
Next filing
Apr 11, 2025

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney